Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, Application In Synthesis of 3-Chloro-6-(methylamino)pyridazine, molecular formula is C5H6ClN3, introducing its new discovery. Application In Synthesis of 3-Chloro-6-(methylamino)pyridazine
2-arylbenzothiophene derivatives or pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient. Since the 2-arylbenzothiophene derivatives of Formula 1 have a relatively high binding affinity for beta-amyloid, they can be used as diagnostic reagents for diagnosing Alzheimer’s disease at an early stage by non-invasive techniques when they are labeled with radioisotopes: wherein R1-R4, V, W, X, Y and Z are as defined in the Detailed Descript of the specification. Further, when the pharmaceutical composition containing the 2-arylbenzothiophene derivative binds with a low-molecular weight beta-amyloid peptide binding compound, generation of malignant high-molecular weight beta-amyloid deposits is minimized. Accordingly, the pharmaceutical composition can be used as a therapeutic agent of degenerative brain disease such as Alzheimer’s disease
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Application In Synthesis of 3-Chloro-6-(methylamino)pyridazine. In my other articles, you can also check out more blogs about 14959-32-1
Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N1025 – PubChem